Bal Pharma Limited Financial Ratios
BALPHARMA · Healthcare · Current price ₹96
P/E ratio
24.3x
P/B ratio
2.1x
ROE
7.6%
ROCE
9.4%
Debt / Equity
1.94
Dividend yield
1.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 24.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 7.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 9.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.94 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Bal Pharma Limited's latest numbers.
Bal Pharma Limited profitability
Bal Pharma Limited generates a return on equity of 7.6% and a return on capital employed of 9.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.94 and a P/E of 24.3x, Bal Pharma Limited is carrying meaningful debt. Our overall business-quality score for the company is 3.3 / 10.
Understand the ratios
More on Bal Pharma Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.